Analysts’ Viewpoint on Rapid Test Market Scenario
Rapid tests are used to quickly and reliably diagnose various diseases. Rise in prevalence of infectious diseases and increase in awareness about early diagnosis of these diseases are driving the demand for rapid test kits. Increase in cases of COVID-19 also augments the global rapid test market size. Accurate and low-cost diagnostic tests are gaining traction worldwide. Rapid tests offer stability at high temperatures and provide results in a short time. These benefits have led to a surge in adoption of rapid tests in point-of-care testing, wherein results are obtained on the same day. Favorable operational dynamics of rapid tests are expected to fuel the global rapid test market during the forecast period. However, product recalls due to false positive results are expected to impede the market. Manufacturers are developing rapid diagnostic tests for COVID-19 diagnosis. They are also adopting a direct-to-consumer distribution approach to enhance their revenue streams.
Rapid test is a diagnostic test used for screening diseases. It can be performed quickly, with conclusive results is 15-30 minutes. Rapid results in diagnostics aid in the timely and effective treatment of diseases. Rapid tests are non-automated procedures that use in vitro diagnostic medical equipment to produce qualitative or semi-quantitative results. These tests are suitable for initial medical screening and can be used in healthcare facilities with limited resources. Point-of-care testing for diseases is also possible with this test, and results are typically available in less than two hours. Veterinary drug residues test kits can also test Beta-lactams, Chloramphenicol, Lincomycin, Tetracyclines, Sulfonamides, Streptomycin, and Quinolones.
Numerous test technologies such as immunoassay, chromatography, spectroscopy, and PCR are used for rapid testing. Immunoassay test identifies and quantifies specific chemicals by utilizing the binding of antibodies to antigens. Immunoassay test results might reveal details about a condition that may aid in treatment planning. Rapid chromatography is another common low-pressure method used in the rapid detection of diseases. It is used for qualitative detection of nucleocapsid antigen present in human nasal samples.
The COVID-19 pandemic has had a positive impact on the rapid diagnostic test market size. It resulted in lockdowns in many countries across the globe. As of August 2022, 600 million infections and 6.4 million deaths were recorded due to COVID-19. The pandemic has strained hospital resources including medical equipment and healthcare professionals. Surge in cases of COVID-19 leads to an increase in demand for rapid diagnostic kits. Thus, key players in the market reported increase in revenue during the peak of the COVID-19 pandemic.
In terms of type, the laboratory rapid test segment accounted for major share of the global market in 2021. Laboratory rapid tests can be carried out at the site of care such as hospitals, medical offices, and clinics. They are easy to use and affordable, which makes them ideal for mass population testing.
The over-the-counter/home-use rapid test segment is expected to grow at a significant pace during the forecast period. The outbreak of COVID-19 led to a surge in demand for home-use rapid tests, as they can be taken anywhere. Over-the-counter/home-use rapid tests provide results in less than 20 minutes.
Based on technology, the immunoassay segment dominated the market in 2021 due to the rise in adoption of immunoassay techniques in diagnosis of various infectious diseases. Immunoassay uses the binding of antibodies to antigens in order to identify and measure certain substances. It is primarily used to detect antigens in Hemophilus, Streptococcus, and Cryptococcus organisms in the Cerebrospinal Fluid (CSF) of meningitis patients. Immunoassays are commonly used to diagnose viral hepatitis, HIV, and Lyme disease.
In terms of application, the COVID-19 test segment dominated the market in 2021. Growth of the segment can be ascribed to the surge in cases of COVID-19 across the globe in the year. Increase in cases of Covid-19 leads to challenges in maintaining demand and supply of rapid tests at affordable cost. Thus, governments across the globe are investing significantly to boost the production of rapid tests. In September 2020, the U.K.’s Moonshot Program announced plans to invest more than US$100 Bn in order to systematically evaluate, develop, and integrate new technologies for COVID-19 rapid result testing, including RATs for COVID-19.
Based on end-user, the hospitals segment accounted for the largest share of the market in 2021. Presence of a strong network of healthcare experts in hospital settings is driving the segment. Patients are admitted to hospitals for the treatment of various diseases such as diabetes, HIV, influenza virus, and chikungunya virus infection. Hospitals conduct rapid tests before patients undergo suitable treatment.
North America is projected to dominate the global rapid test market during the forecast period. Increase in awareness about infectious diseases, rise in healthcare expenditure, and surge in availability of advanced rapid tests are driving the market in the region.
The market in Asia Pacific is anticipated to grow at a high CAGR during the forecast period due to the rise in prevalence of infectious diseases in the region. Increase in geriatric population, surge in healthcare expenditure, and rise in patient awareness about rapid tests are also fueling the market in Asia Pacific.
The rapid test market research report includes vital information about leading players in the global market. The report also covers the allergy rapid test market and the veterinary rapid test market. Companies are adopting product launch, divestiture, merger & acquisition, and partnership strategies to enhance their rapid test market share. Abbott Laboratories, Hologic, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Quidel Corporation., Meridian Bioscience Inc., Elabscience Biotechnology Inc., and OraSure Technologies are prominent players operating in the global market.
Each of these players has been profiled in the global rapid test market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 28.51 Bn |
|
Market Forecast Value in 2031 |
More than US$ 62.34 Bn |
|
Growth Rate (CAGR) for 2022–2031 |
8.0% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global rapid test market was valued at US$ 28.51 Bn in 2021
The global market is projected to reach more than US$ 62.34 Bn by 2031
The global rapid test market is anticipated to grow at a CAGR of 8.0% from 2022 to 2031
Increase in prevalence of infectious diseases and rise in advancements in rapid diagnostic testing
North America is expected to account for major share of the global rapid test market during the forecast period
Abbott Laboratories, Hologic, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Quidel Corporation, Meridian Bioscience Inc., Elabscience Biotechnology Inc., and OraSure Technologies
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Rapid Test Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Rapid Test Market Analysis and Forecasts, 2017 - 2031
5. Key Insights
5.1. Top Players Operating in the Market Space
5.2. Disease Prevalence & Incidence Rate, Globally with Key Countries
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)
6. Global Rapid Test Market Analysis and Forecasts, By Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast By Type, 2017 - 2031
6.3.1. Laboratory Rapid Test
6.3.2. Over-the-counter/Home-use Rapid Test
6.4. Market Attractiveness By Type
7. Global Rapid Test Market Analysis and Forecasts, By Technology
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast By Technology, 2017 - 2031
7.3.1. Immunoassay
7.3.2. Chromatography
7.3.3. Spectroscopy
7.3.4. PCR
7.3.5. Others
7.4. Market Attractiveness By Technology
8. Global Rapid Test Market Analysis and Forecasts, By Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast By Application, 2017 - 2031
8.3.1. COVID-19 Test
8.3.2. Infectious Disease
8.3.2.1. Influenza
8.3.2.2. Malaria
8.3.2.3. Dengue
8.3.2.4. HIV
8.3.2.5. Others
8.3.3. Glucose Test
8.3.4. Pregnancy Test
8.3.5. Cholesterol Test
8.3.6. Others
8.4. Market Attractiveness By Application
9. Global Rapid Test Market Analysis and Forecasts, By End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast By End-user, 2017 - 2031
9.3.1. Hospitals
9.3.2. Home Care
9.3.3. Diagnostic Centers
9.3.4. Others
9.4. Market Attractiveness By End-user
10. Global Rapid Test Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Rapid Test Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Type, 2017 - 2031
11.2.1. Laboratory Rapid Test
11.2.2. Over-the-counter/Home-use Rapid Test
11.3. Market Value Forecast By Technology, 2017 - 2031
11.3.1. Immunoassay
11.3.2. Chromatography
11.3.3. Spectroscopy
11.3.4. PCR
11.3.5. Others
11.4. Market Value Forecast By Application, 2017 - 2031
11.4.1. COVID-19 Test
11.4.2. Infectious Disease
11.4.2.1. Influenza
11.4.2.2. Malaria
11.4.2.3. Dengue
11.4.2.4. HIV
11.4.2.5. Others
11.4.3. Glucose Test
11.4.4. Pregnancy Test
11.4.5. Cholesterol Test
11.4.6. Others
11.5. Market Value Forecast By End-user, 2017 - 2031
11.5.1. Hospitals
11.5.2. Home Care
11.5.3. Diagnostic Centers
11.5.4. Others
11.6. Market Value Forecast By Country, 2017 - 2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Technology
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Rapid Test Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Type, 2017 - 2031
12.2.1. Laboratory Rapid Test
12.2.2. Over-the-counter/Home-use Rapid Test
12.3. Market Value Forecast By Technology, 2017 - 2031
12.3.1. Immunoassay
12.3.2. Chromatography
12.3.3. Spectroscopy
12.3.4. PCR
12.3.5. Others
12.4. Market Value Forecast By Application, 2017 - 2031
12.4.1. COVID-19 Test
12.4.2. Infectious Disease
12.4.2.1. Influenza
12.4.2.2. Malaria
12.4.2.3. Dengue
12.4.2.4. HIV
12.4.2.5. Others
12.4.3. Glucose Test
12.4.4. Pregnancy Test
12.4.5. Cholesterol Test
12.4.6. Others
12.5. Market Value Forecast By End-user, 2017 - 2031
12.5.1. Hospitals
12.5.2. Home Care
12.5.3. Diagnostic Centers
12.5.4. Others
12.6. Market Value Forecast By Country, 2017 - 2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Technology
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country
13. Asia Pacific Rapid Test Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Type, 2017 - 2031
13.2.1. Laboratory Rapid Test
13.2.2. Over-the-counter/Home-use Rapid Test
13.3. Market Value Forecast By Technology, 2017 - 2031
13.3.1. Immunoassay
13.3.2. Chromatography
13.3.3. Spectroscopy
13.3.4. PCR
13.3.5. Others
13.4. Market Value Forecast By Application, 2017 - 2031
13.4.1. COVID-19 Test
13.4.2. Infectious Disease
13.4.2.1. Influenza
13.4.2.2. Malaria
13.4.2.3. Dengue
13.4.2.4. HIV
13.4.2.5. Others
13.4.3. Glucose Test
13.4.4. Pregnancy Test
13.4.5. Cholesterol Test
13.4.6. Others
13.5. Market Value Forecast By End-user, 2017 - 2031
13.5.1. Hospitals
13.5.2. Home Care
13.5.3. Diagnostic Centers
13.5.4. Others
13.6. Market Value Forecast By Country, 2017 - 2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Technology
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country
14. Latin America Rapid Test Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Type, 2017 - 2031
14.2.1. Laboratory Rapid Test
14.2.2. Over-the-counter/Home-use Rapid Test
14.3. Market Value Forecast By Technology, 2017 - 2031
14.3.1. Immunoassay
14.3.2. Chromatography
14.3.3. Spectroscopy
14.3.4. PCR
14.3.5. Others
14.4. Market Value Forecast By Application, 2017 - 2031
14.4.1. COVID-19 Test
14.4.2. Infectious Disease
14.4.2.1. Influenza
14.4.2.2. Malaria
14.4.2.3. Dengue
14.4.2.4. HIV
14.4.2.5. Others
14.4.3. Glucose Test
14.4.4. Pregnancy Test
14.4.5. Cholesterol Test
14.4.6. Others
14.5. Market Value Forecast By End-user, 2017 - 2031
14.5.1. Hospitals
14.5.2. Home Care
14.5.3. Diagnostic Centers
14.5.4. Others
14.6. Market Value Forecast By Country, 2017 - 2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Technology
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country
15. Middle East & Africa Rapid Test Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Type, 2017 - 2031
15.2.1. Laboratory Rapid Test
15.2.2. Over-the-counter/Home-use Rapid Test
15.3. Market Value Forecast By Technology, 2017 - 2031
15.3.1. Immunoassay
15.3.2. Chromatography
15.3.3. Spectroscopy
15.3.4. PCR
15.3.5. Others
15.4. Market Value Forecast By Application, 2017 - 2031
15.4.1. COVID-19 Test
15.4.2. Infectious Disease
15.4.2.1. Influenza
15.4.2.2. Malaria
15.4.2.3. Dengue
15.4.2.4. HIV
15.4.2.5. Others
15.4.3. Glucose Test
15.4.4. Pregnancy Test
15.4.5. Cholesterol Test
15.4.6. Others
15.5. Market Value Forecast By End-user, 2017 - 2031
15.5.1. Hospitals
15.5.2. Home Care
15.5.3. Diagnostic Centers
15.5.4. Others
15.6. Market Value Forecast By Country, 2017 - 2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Type
15.7.2. By Technology
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis By Company (2021)
16.3. Company Profiles
16.3.1. Abbott Laboratories
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. SWOT Analysis
16.3.1.4. Strategic Overview
16.3.2. Hologic, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. SWOT Analysis
16.3.2.4. Strategic Overview
16.3.3. Becton, Dickinson and Company
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. SWOT Analysis
16.3.3.4. Strategic Overview
16.3.4. F. Hoffmann-La Roche Ltd.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. SWOT Analysis
16.3.4.4. Strategic Overview
16.3.5. Danaher Corporation
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. SWOT Analysis
16.3.5.4. Strategic Overview
16.3.6. Thermo Fisher Scientific, Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. SWOT Analysis
16.3.6.4. Strategic Overview
16.3.7. Bio-Rad Laboratories, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. SWOT Analysis
16.3.7.4. Strategic Overview
16.3.8. PerkinElmer, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. SWOT Analysis
16.3.8.4. Strategic Overview
16.3.9. Quidel Corporation
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. SWOT Analysis
16.3.9.4. Strategic Overview
16.3.10. Meridian Bioscience Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. SWOT Analysis
16.3.10.4. Strategic Overview
16.3.11. Elabscience Biotechnology Inc.
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. SWOT Analysis
16.3.11.4. Strategic Overview
16.3.12. OraSure Technologies
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. SWOT Analysis
16.3.12.4. Strategic Overview
List of Tables
Table 01: Global Rapid Test Market Value (US$ Mn) Forecast, by Type, 2022 and 2031
Table 02: Global Rapid Test Market Value (US$ Mn) Forecast, by Technology, 2022 and 2031
Table 03: Global Rapid Test Market Value (US$ Mn) Forecast, by Application, 2022 and 2031
Table 04: Global Rapid Test Market Value (US$ Mn) Forecast, by End-user, 2022 and 2031
Table 05: Global Rapid Test Market Value (US$ Mn) Forecast, by Region, 2022 and 2031
Table 06: North America Rapid Test Market Value (US$ Mn) Forecast, by Country, 2022 and 2031
Table 07: North America Rapid Test Market Value (US$ Mn) Forecast, by Type, 2022 and 2031
Table 08: North America Rapid Test Market Value (US$ Mn) Forecast, by Technology, 2022 and 2031
Table 09: North America Rapid Test Market Value (US$ Mn) Forecast, by Application 2022 and 2031
Table 10: North America Rapid Test Market Value (US$ Mn) Forecast, by End-user, 2022 and 2031
Table 11: Europe Rapid Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022 and 2031
Table 12: Europe Rapid Test Market Value (US$ Mn) Forecast, by Type, 2022 and 2031
Table 13: Europe Rapid Test Market Value (US$ Mn) Forecast, by Technology, 2022 and 2031
Table 14: Europe Rapid Test Market Value (US$ Mn) Forecast, by Application, 2022 and 2031
Table 15: Europe Rapid Test Market Value (US$ Mn) Forecast, by End-user, 2022 and 2031
Table 16: Asia Pacific Rapid Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022 and 2031
Table 17: Asia Pacific Rapid Test Market Value (US$ Mn) Forecast, by Type, 2022 and 2031
Table 18: Asia Pacific Rapid Test Market Value (US$ Mn) Forecast, by Technology, 2022 and 2031
Table 19: Asia Pacific Rapid Test Market Value (US$ Mn) Forecast, by Application, 2022 and 2031
Table 20: Asia Pacific Rapid Test Market Value (US$ Mn) Forecast, by End-user, 2022 and 2031
Table 21: Latin America Rapid Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022 and 2031
Table 22: Latin America Rapid Test Market Value (US$ Mn) Forecast, by Type, 2022 and 2031
Table 23: Latin America Rapid Test Market Value (US$ Mn) Forecast, by Technology, 2022 and 2031
Table 24: Latin America Rapid Test Market Value (US$ Mn) Forecast, by Application, 2022 and 2031
Table 25: Latin America Rapid Test Market Value (US$ Mn) Forecast, by End-user, 2022 and 2031
Table 26: Middle East & Africa Rapid Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022 and 2031
Table 27: Middle East & Africa Rapid Test Market Value (US$ Mn) Forecast, by Type, 2022 and 2031
Table 28: Middle East & Africa Rapid Test Market Value (US$ Mn) Forecast, by Technology 2022 and 2031
Table 29: Middle East & Africa Rapid Test Market Value (US$ Mn) Forecast, by Application 2022 and 2031
Table 30: Middle East & Africa Rapid Test Market Value (US$ Mn) Forecast, by End-user 2022 and 2031
List of Figures
Figure 01: Global Rapid Test Market Value Share Analysis, by Type, 2022 and 2031
Figure 02: Global Rapid Test Market Value Share Analysis, by Technology, 2022 and 2031
Figure 03: Global Rapid Test Market Value Share Analysis, by Application, 2022 and 2031
Figure 04: Global Rapid Test Market Value Share Analysis, by End-user, 2022 and 2031
Figure 05: Global Rapid Test Market Attractiveness Analysis, by Type, 2022–2031
Figure 06: Global Rapid Test Market Attractiveness Analysis, by Application, 2022–2031
Figure 07: Global Rapid Test Market Attractiveness Analysis, by Technology, 2022–2031
Figure 08: Global Rapid Test Market Attractiveness Analysis, by End-user, 2022–2031
Figure 09: North America Rapid Test Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 10: North America Rapid Test Market Value Share (%), by Country, 2022 and 2031
Figure 11: North America Rapid Test Market Attractiveness Analysis, by Country, 2022–2031
Figure 12: North America Rapid Test Market Attractiveness Analysis, by Type, 2022–2031
Figure 13: North America Rapid Test Market Attractiveness Analysis, by Technology, 2022–2031
Figure 14: North America Rapid Test Market Attractiveness Analysis, by Application, 2022–2031
Figure 15: North America Rapid Test Market Attractiveness Analysis, by End-user, 2022–2031
Figure 16: North America Treatment Market Value Share Analysis, by Type, 2022 and 2031
Figure 17: North America Rapid Test Market Value Share Analysis, by Technology, 2022 and 2031
Figure 18: North America Rapid Test Market Value Share Analysis, by Application, 2022 and 2031
Figure 19: North America Rapid Test Market Value Share Analysis, by End-user, 2022 and 2031
Figure 20: Europe Rapid Test Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 21: Europe Rapid Test Market Value Share (%), by Country/Sub-region, 2022 and 2031
Figure 22: Europe Rapid Test Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 23: Europe Rapid Test Market Value Share Analysis, by Type, 2022 and 2031
Figure 24: Europe Rapid Test Market Attractiveness Analysis, by Technology, 2022–2031
Figure 25: Europe Rapid Test Market Attractiveness Analysis, by Application, 2022–2031
Figure 26: Europe Rapid Test Market Attractiveness Analysis, by End-user, 2022–2031
Figure 27: Europe Rapid Test Market Value Share Analysis, by Type, 2022 and 2031
Figure 28: Europe Rapid Test Market Value Share Analysis, by Technology, 2022 and 2031
Figure 29: Europe Rapid Test Market Value Share Analysis, by Application, 2022 and 2031
Figure 30: Europe Rapid Test Market Value Share Analysis, by End-user, 2022 and 2031
Figure 31: Asia Pacific Rapid Test Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 32: Asia Pacific Rapid Test Market Value Share (%), by Country/Sub-region, 2022 and 2031
Figure 33: Asia Pacific Rapid Test Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 34: Asia Pacific Rapid Test Market Value Share Analysis, by Type, 2022 and 2031
Figure 35: Asia Pacific Rapid Test Market Value Share Analysis, by Technology, 2022 and 2031
Figure 36: Asia Pacific Rapid Test Market Value Share Analysis, by Application, 2022 and 2031
Figure 37: Asia Pacific Rapid Test Market Value Share Analysis, by End-user, 2022 and 2031
Figure 38: Asia Pacific Rapid Test Market Attractiveness Analysis, by Type, 2022–2031
Figure 39: Asia Pacific Rapid Test Market Attractiveness Analysis, by Technology, 2022–2031
Figure 40: Asia Pacific Rapid Test Market Attractiveness Analysis, by Application, 2022–2031
Figure 41: Asia Pacific Rapid Test Market Attractiveness Analysis, by End-user, 2022–2031
Figure 42: Latin America Rapid Test Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 43: Latin America Rapid Test Market Value Share (%), by Country/Sub-region, 2022 and 2031
Figure 44: Latin America Rapid Test Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 45: Latin America Rapid Test Market Value Share Analysis, by Type, 2022 and 2031
Figure 46: Latin America Rapid Test Market Value Share Analysis, by Technology, 2022 and 2031
Figure 47: Latin America Rapid Test Market Value Share Analysis, by Application, 2022 and 2031
Figure 48: Latin America Rapid Test Market Value Share Analysis, by End-user, 2022 and 2031
Figure 49: Latin America Rapid Test Market Attractiveness Analysis, by Type, 2022–2031
Figure 50: Latin America Rapid Test Market Attractiveness Analysis, by Technology, 2022–2031
Figure 51: Latin America Rapid Test Market Attractiveness Analysis, by Application, 2022–2031
Figure 52: Latin America Rapid Test Market Attractiveness Analysis, by End-user, 2022–2031
Figure 53: Middle East & Africa Rapid Test Market Value Share (%), by Country/Sub-region, 2022 and 2031
Figure 54: Middle East & Africa Rapid Test Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 55: Middle East & Africa Rapid Test Market Value Share Analysis, by Type, 2022 and 2031
Figure 56: Middle East & Africa Rapid Test Market Value Share Analysis, by Technology, 2022 and 2031
Figure 57: Middle East & Africa Rapid Test Market Value Share Analysis, by Application, 2022 and 2031
Figure 58: Middle East & Africa Rapid Test Market Value Share Analysis, End-user, 2022 and 2031
Figure 59: Middle East & Africa Rapid Test Market Attractiveness Analysis, by Type, 2022–2031
Figure 60: Middle East & Africa Rapid Test Market Attractiveness Analysis, by Technology, 2022–2031
Figure 61: Middle East & Africa Rapid Test Market Attractiveness Analysis, by Application, 2022–2031
Figure 62: Middle East & Africa Rapid Test Market Attractiveness Analysis, by End-user, 2022–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Rapid Test Market
